Advanced Medical Optics (AMO) has completed its acquisition of IntraLase Corp.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Fungal infection and vision impact in patients with diabetic eye disease
Rhino-orbital-cerebral mucormycosis, a life-threatening fungal infection, typically occurs in patients with diabetes
Higher Molar Dose and Its Translation into Clinical Practice
Nicox and Kowa enter commercialisation agreement for NCX 470 glaucoma eye drop
The nitric oxide-donating bimatoprost therapy is intended to lower intraocular pressure in patients with glaucoma or ocular hypertension
Germany serves as European launch point for low-dose atropine from Santen (Ryjunea)
The SYD-101 atropine formulation is licensed by Santen SA, based in Switzerland, from Sydnexis Inc, based in California
AI-powered Eye2Gene uses multimodal imaging to diagnose inherited retinal disease
The platform, developed by University College London and Heidelberg Engineering, demonstrated accuracy and precision in early tests
Q&A: Early research findings and clinical experiences with a new multifocal IOL
Frank Kerkhoff, MD, shares his experiences with the Johnson & Johnson Tecnis Odyssey lens